Orion bringing new contract manufacturing offers to CPhI Madrid

Espoo, Finland:- Leading European research-based life sciences manufacturer Orion Corporation will be a prominent presence at October’s landmark CPhI Worldwide pharma industry show in Madrid.

Orion’s stand at Booth 6H30 in Hall 6 at Madrid’s IFEMA expo centre will provide a comprehensive showcase of its many services and products for the pharmaceutical industry.

Contract manufacturing

The Orion team at CPhI 2015 will include strong representation from the corporation’s contract manufacturing arm, with details of key new capabilities and product ranges. The team’s aim is to increase awareness of Orion’s advanced CMO capabilities.

These include Orion’s particular specialty areas in hormonal semi-solids, gels and solutions, produced to very high quality standards from the group’s recently extended manufacturing facility in Finland. Orion also offers formulation and filling of semi-solids (solutions, creams, gels) and sterile liquids, tablets and packaging.

Steriles and injectables

The Orion team will also have details of capabilities and capacity available for new sterile and injectable products as well as key licensing and custom manufacturing opportunities. Orion also offers contract packaging and serialization services.

CPhI Worldwide is a key event for Orion, with the group having been a consistent presence at the show almost since it was first staged in 1989.

The Orion show team will use CPhI’s extensive networking facilities to reach out to existing and potential customers and other business contacts. They are inviting any attendees interested in face-to-face meetings to contact the company in advance to set up face-to-face meetings.

About Orion Corporation

Orion develops and provides pharmaceuticals and diagnostic tests to global markets. The company has been an innovative presence in well-being and life sciences since 1917; initially in its native country Finland and now with direct presence in 21 European countries.

Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods.

Product and service offerings from Orion and its sister company Fermion involve APIs and finished dosage forms as well as a capable marketing and sales network made available for partners’ licensing opportunities. Both Orion and Fermion also offer high value pharmaceutical contract manufacturing services for global markets.

Orion is a clear market leader in its main market Finland and also markets its products in more than 100 countries worldwide. The Group’s human pharmaceuticals sales organisation covers almost all key European markets. Several collaboration partners distribute Orion products in overseas markets.
All Orion manufacturing and most of its R&D operations are in Finland, with the group headquarters in Espoo, a short distance west of Helsinki. Orion employs some 3,500 people and in 2014 reported total worldwide sales of EUR 1,015 million (2013: EUR 1,007 m.). Orion A and B shares are listed on NASDAQ OMX Helsinki.

About CPhI 2015

CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.

Now in its 26th year, the 2015 event is a three-day event opening October 13 at IFEMA, Feria de Madrid. Last year’s show in Paris attracted almost 36,500 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.

The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

The Pre-Connect Conference on October 12 brings together senior representatives and key stakeholders from all segments of the industry for a series of market-led educational modules on the latest trends and topics with networking and partnering opportunities.

The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders. The previous three categories (formulation, process development and packaging) have now been expanded to eight awards, now additionally honoring best innovations in biologic drug development and manufacturing, supply chain & logistic management, manufacturing technology, APIs and excipients, as well as CEO of the Year.

The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/home